FlashRX - Top 250 Drugs
FlashRX - Top 250 Drugs generates an estimated $7–$200/month in revenue from 4–20 downloads/month on Google Play, according to AppCurrents estimates (updated 2026-08-02).
| Est. revenue / month | $7–$200 |
|---|---|
| Est. downloads / month | 4–20 |
| Estimate confidence | medium |
| Pricing | Paid $4.99 |
| Rating | 4.62 ★ (159 ratings) |
| Category | Medical |
| Best chart rank | #200 Medical Grossing |
| Released | 26.05.2013 |
| App last updated | 19.07.2024 |
| Platform | Android |
Measured monthly estimate · Play installs · medium confidence
About
IMPORTANT: FlashRX is currently still available to download but is no longer supported or updated. A new app with similar functionality ("RxFlip" by ClinCalc) is now available with a modern, sleek interface, new functionality, and a completely revamped drug database. *************** FlashRX is a flashcard and quiz-based educational tool for healthcare students and professionals to learn the top…
Trends & analysis
Chart rank trend
US · categoryWhy it's surfacing
Scout 13Ratings & velocity
★ 0 in windowRating distribution
92% positive · 157 ratingsGeographic reach
best rank · 1 storefrontRevenue & downloads trend
ARPU $4FlashRX - Top 250 Drugs — FAQ
How much money does FlashRX - Top 250 Drugs make?
According to AppCurrents estimates, FlashRX - Top 250 Drugs generates approximately $7–$200 per month (medium confidence), modeled from its Google Play chart performance, rating velocity, and monetization signals.
How many downloads does FlashRX - Top 250 Drugs get?
FlashRX - Top 250 Drugs sees an estimated 4–20 downloads per month on Google Play, per AppCurrents modeling.
Is FlashRX - Top 250 Drugs free?
FlashRX - Top 250 Drugs is a paid app priced at $4.99 on Google Play.
What is FlashRX - Top 250 Drugs's rating?
FlashRX - Top 250 Drugs holds a 4.62-star average from 159 ratings on Google Play. It currently ranks #200 on the Medical grossing chart.
When was FlashRX - Top 250 Drugs released?
FlashRX - Top 250 Drugs launched on Google Play on 26.05.2013. Its latest version shipped 19.07.2024.